SenolyticEmerging
Quercetin (with bromelain)
Flavonoid with anti-inflammatory and senolytic properties (studied alongside dasatinib). Poor oral bioavailability.
Goals
Longevity (broad)CardiovascularImmune
Timing
Pulse dosed
Price tier
Medium
Dosage
500–1,000 mg/day. Bromelain or lipid-based formulations improve absorption.
Considerations
Senolytic effect in humans shown primarily in combination with dasatinib — mono-quercetin effects unclear.
Form
Capsule
Scientific detail
Senolytische ClearanceAntioxidansHistamin-Stabilisierung
Cellular senescenceChronic inflammation
Evidence base